tradingkey.logo
tradingkey.logo
Search

QuidelOrtho Corp

QDEL
Add to Watchlist
10.320USD
-1.070-9.39%
Close 05/15, 16:00ETQuotes delayed by 15 min
703.73MMarket Cap
LossP/E TTM

QuidelOrtho Corp

10.320
-1.070-9.39%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of QuidelOrtho Corp

Currency: USD Updated: 2026-05-15

Key Insights

QuidelOrtho Corp's fundamentals are relatively weak, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 80 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 18.88.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

QuidelOrtho Corp's Score

Industry at a Glance

Industry Ranking
80 / 206
Overall Ranking
200 / 4482
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

QuidelOrtho Corp Highlights

StrengthsRisks
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 2.73B.
Overvalued
The company’s latest PE is -0.58, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 88.33M shares, decreasing 13.83% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 294.15K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.38.

Analyst Rating

Based on 6 analysts
Hold
Current Rating
18.875
Target Price
+65.72%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-15

The current financial score of QuidelOrtho Corp is 5.71, ranking 187 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 619.80M, representing a year-over-year decrease of 10.54%, while its net profit experienced a year-over-year decrease of 622.83%.

Score

Industry at a Glance

Previous score
5.71
Change
0

Financials

3.68

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

6.05

Operational Efficiency

6.24

Growth Potential

6.43

Shareholder Returns

6.14

QuidelOrtho Corp's Company Valuation

Currency: USD Updated: 2026-05-15

The current valuation score of QuidelOrtho Corp is 8.38, ranking 23 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.58, which is -1737.73% below the recent high of 9.47 and -85394.90% above the recent low of -494.25.

Score

Industry at a Glance

Previous score
8.38
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 80/206
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-15

The current earnings forecast score of QuidelOrtho Corp is 6.75, ranking 163 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 32.00, with a high of 60.00 and a low of 22.00.

Score

Industry at a Glance

Previous score
6.75
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 6 analysts
Hold
Current Rating
18.875
Target Price
+65.72%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

93
Total
4
Median
7
Average
Company name
Ratings
Analysts
QuidelOrtho Corp
QDEL
6
Boston Scientific Corp
BSX
37
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
35
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
19

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-15

The current price momentum score of QuidelOrtho Corp is 5.96, ranking 163 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 12.57 and the support level at 9.00, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.41
Change
-0.45

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.268
Neutral
RSI(14)
36.942
Neutral
STOCH(KDJ)(9,3,3)
27.744
Neutral
ATR(14)
0.957
High Vlolatility
CCI(14)
-73.255
Neutral
Williams %R
86.348
Oversold
TRIX(12,20)
-1.320
Sell
StochRSI(14)
52.566
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
10.768
Sell
MA10
11.045
Sell
MA20
11.543
Sell
MA50
14.492
Sell
MA100
21.172
Sell
MA200
24.050
Sell

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of QuidelOrtho Corp is 10.00, ranking 1 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 129.53%, representing a quarter-over-quarter increase of 4.67%. The largest institutional shareholder is PRFDX, holding a total of 903.09K shares, representing 1.32% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
9.46M
+1.48%
T. Rowe Price Investment Management, Inc.
11.83M
+7.45%
Fidelity Management & Research Company LLC
5.37M
+20.98%
Rubric Capital Management LP
3.78M
-18.56%
Invesco Advisers, Inc.
3.24M
+21.58%
Dimensional Fund Advisors, L.P.
2.84M
-0.81%
Newtyn Management, LLC
3.01M
+11.65%
State Street Investment Management (US)
2.70M
+1.33%
1
2

Risk Assessment

Currency: USD Updated: 2026-05-15

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of QuidelOrtho Corp is 4.84, ranking 94 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.74. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. QuidelOrtho Corp’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

Score

Industry at a Glance

Previous score
4.84
Change
0
Beta vs S&P 500 index
0.71
VaR
+4.96%
240-Day Maximum Drawdown
+71.85%
240-Day Volatility
+72.22%

Return

Best Daily Return
60 days
+16.10%
120 days
+16.10%
5 years
+41.04%
Worst Daily Return
60 days
-27.47%
120 days
-27.47%
5 years
-32.20%
Sharpe Ratio
60 days
-2.91
120 days
-1.21
5 years
-0.62

Risk Assessment

Maximum Drawdown
240 days
+71.85%
3 years
+88.76%
5 years
+94.30%
Return-to-Drawdown Ratio
240 days
-0.91
3 years
-0.33
5 years
-0.20
Skewness
240 days
-0.90
3 years
+0.29
5 years
+0.14

Volatility

Realised Volatility
240 days
+72.22%
5 years
+56.01%
Standardised True Range
240 days
+13.87%
5 years
+27.45%
Downside Risk-Adjusted Return
120 days
-152.60%
240 days
-152.60%
Maximum Daily Upside Volatility
60 days
+81.95%
Maximum Daily Downside Volatility
60 days
+82.73%

Liquidity

Average Turnover Rate
60 days
+3.26%
120 days
+2.43%
5 years
--
Turnover Deviation
20 days
+97.93%
60 days
+66.64%
120 days
+24.20%

Peer Comparison

Healthcare Equipment & Supplies
QuidelOrtho Corp
QuidelOrtho Corp
QDEL
6.71 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
Bruker Corp
BRKR
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI